GW Pharma CEO: Europe Epidyolex Launch | Mad Money | CNBC



The European Union has approved GW Pharma’s CBD-based drug Epidyolex to treat seizures related to epilepsy. CEO Justin Gover explains its prospects to …

2 Comments

Leave a Reply

Your email address will not be published.